HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 303 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $4,659,968 | -63.2% | 54,733 | -64.2% | 0.01% | -68.8% |
Q1 2023 | $12,657,606 | -29.8% | 152,962 | -37.2% | 0.03% | -41.8% |
Q3 2022 | $18,039,000 | -49.4% | 243,677 | -55.4% | 0.06% | -52.6% |
Q2 2022 | $35,632,000 | +89.2% | 546,676 | +53.9% | 0.12% | +81.2% |
Q4 2021 | $18,836,000 | -21.7% | 355,127 | +4.2% | 0.06% | -36.0% |
Q3 2021 | $24,058,000 | +2873.8% | 340,816 | +2708.8% | 0.10% | +2400.0% |
Q2 2021 | $809,000 | -95.9% | 12,134 | -92.6% | 0.00% | -96.3% |
Q4 2020 | $19,587,000 | -14.3% | 164,944 | -37.0% | 0.11% | -35.1% |
Q3 2020 | $22,861,000 | +101.9% | 262,020 | +107.3% | 0.17% | +71.4% |
Q2 2020 | $11,323,000 | -43.7% | 126,424 | -27.8% | 0.10% | -18.3% |
Q4 2019 | $20,121,000 | +2499.6% | 175,119 | +1879.6% | 0.12% | +2300.0% |
Q1 2019 | $774,000 | +74.3% | 8,846 | +78.6% | 0.01% | +150.0% |
Q2 2018 | $444,000 | +28.0% | 4,953 | -35.9% | 0.00% | +100.0% |
Q3 2017 | $347,000 | -86.7% | 7,730 | -88.3% | 0.00% | -90.9% |
Q2 2017 | $2,618,000 | – | 66,300 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
Dean Capital Management | 15,309 | $812,000 | 0.70% |
Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |